against MHC-molecules

Industry

CPC
C07K16/2833

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07KPEPTIDES C07K16/00Immunoglobulins [IGs]

Current Industry

C07K16/2833against MHC-molecules

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Peptides and combination of peptides for use in immunotherapy again...
- Patent number 12,168,044
- Issue date Dec 17, 2024
- Immatics Biotechnologies GmbH
- Toni Weinschenk
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
MAGE-A4 peptide dual T cell engagers
- Patent number 12,161,673
- Issue date Dec 10, 2024
- CDR-LIFE AG
- Stephanie Jungmichel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
BMA031 antigen binding polypeptides
- Patent number 12,162,940
- Issue date Dec 10, 2024
- Immatics Biotechnologies GmbH
- Sebastian Bunk
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CCR8 peptide and T cells for use in immunotherapeutic treatment of...
- Patent number 12,156,905
- Issue date Dec 3, 2024
- Immatics Biotechnologies GmbH
- Andrea Mahr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-HLA-G antibodies and methods of use thereof
- Patent number 12,157,770
- Issue date Dec 3, 2024
- HOFFMANN-LA ROCHE INC.
- Stefan Dengl
- G01 - MEASURING TESTING
Information Patent Grant
Peptides and combination of peptides and scaffolds thereof for use...
- Patent number 12,150,979
- Issue date Nov 26, 2024
- Immatics Biotechnologies GmbH
- Oliver Schoor
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Immunotherapy targeting tumor neoantigenic peptides
- Patent number 12,152,077
- Issue date Nov 26, 2024
- Institut Curie
- Sebastian Amigorena
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modified A1-A2 domains of non-natural NKG2D ligands that bind non-n...
- Patent number 12,145,976
- Issue date Nov 19, 2024
- Xyphos Biosciences Inc.
- Kaman C. Kim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
T cell modification and use thereof
- Patent number 12,145,990
- Issue date Nov 19, 2024
- ADAPTIMMUNE LIMITED
- Garth Hamilton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
MIC antibodies and binding agents and methods of using the same
- Patent number 12,139,539
- Issue date Nov 12, 2024
- CanCure, LLC
- Jennifer Wu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-human papillomavirus (HPV) antigen-binding proteins and method...
- Patent number 12,115,216
- Issue date Oct 15, 2024
- REGENERON PHARMACEUTICALS, INC.
- Kevin A. Bray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Single domain antibodies targeting CD1d
- Patent number 12,110,328
- Issue date Oct 8, 2024
- LAVA THERAPEUTICS N.V.
- Johannes Jelle Van Der Vliet
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies binding to HLA-A2/WT1
- Patent number 12,098,213
- Issue date Sep 24, 2024
- HOFFMANN-LA ROCHE INC.
- Joerg Benz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Peptides and combination of peptides for use in immunotherapy again...
- Patent number 12,098,183
- Issue date Sep 24, 2024
- Heiko Schuster
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunotherapy with B*07 restricted peptides and combination of pept...
- Patent number 12,084,486
- Issue date Sep 10, 2024
- Immatics Biotechnologies GmbH
- Heiko Schuster
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
A*03 restricted peptides for use in immunotherapy against cancers a...
- Patent number 12,076,379
- Issue date Sep 3, 2024
- Immatics Biotechnologies GmbH
- Colette Song
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptides and combination of peptides for use in immunotherapy again...
- Patent number 12,071,458
- Issue date Aug 27, 2024
- Immatics Biotechnologies GmbH
- Andrea Mahr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-MICA/B antibodies that block MICA/B shedding and methods of use
- Patent number 12,065,493
- Issue date Aug 20, 2024
- Cullinan Mica Corporation
- Neil Gibson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Peptides and combination of peptides for use in immunotherapy again...
- Patent number 12,065,477
- Issue date Aug 20, 2024
- Immatics Biotechnologies GmbH
- Heiko Schuster
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Peptides and combination of peptides and scaffolds for use in immun...
- Patent number 12,059,458
- Issue date Aug 13, 2024
- Immatics Biotechnologies GmbH
- Andrea Mahr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Peptides for use in immunotherapy against cancers
- Patent number 12,060,400
- Issue date Aug 13, 2024
- Immatics Biotechnologies GmbH
- Colette Song
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
T cell receptors
- Patent number 12,060,404
- Issue date Aug 13, 2024
- ADAPTIMMUNE LIMITED
- Nicholas Tribble
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-ULBP6 antibodies
- Patent number 12,060,426
- Issue date Aug 13, 2024
- 23andMe, Inc.
- Joel Benjamin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptides and combination of peptides for use in immunotherapy again...
- Patent number 12,060,406
- Issue date Aug 13, 2024
- Immatics Biotechnologies GmbH
- Andrea Mahr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-hla-A2 antibodies and methods of using the same
- Patent number 12,049,504
- Issue date Jul 30, 2024
- The University of British Columbia
- Megan Levings
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Labeling of antibodies
- Patent number 12,048,753
- Issue date Jul 30, 2024
- Whitehead Institute for Biomedical Research
- Mohammad Rashidian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Target peptides for immunotherapy and diagnostics
- Patent number 12,042,530
- Issue date Jul 23, 2024
- University of Virginia Patent Foundation
- Donald F. Hunt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptides and combination of peptides as targets or active ingredien...
- Patent number 12,036,271
- Issue date Jul 16, 2024
- Immatics Biotechnologies GmbH
- Andrea Mahr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
LILRB1-based chimeric antigen receptor
- Patent number 12,037,377
- Issue date Jul 16, 2024
- A2 Biotherapeutics, Inc.
- Carl Alexander Kamb
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
GINS2 peptide and T cells for use in immunotherapeutic treatment of...
- Patent number 12,029,785
- Issue date Jul 9, 2024
- Immatics Biotechnologies GmbH
- Andrea Mahr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
AUGMENTATION OF INNATE AND ADAPTIVE IMMUNITY BY INHIBITION OF INTER...
- Publication number 20240409640
- Publication date Dec 12, 2024
- THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF...
- Ethan Menahem Shevach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DUAL ACTING CD1D IMMUNOGLOBULIN FOR TREATMENT OF MYELODYSPLASTIC SY...
- Publication number 20240409641
- Publication date Dec 12, 2024
- LAVA THERAPEUTICS N.V.
- Johannes Jelle VAN DER VLIET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONVERSION-RESISTANT / CONDITION-RESISTANT TREGS AND CAR TREGS, MET...
- Publication number 20240408201
- Publication date Dec 12, 2024
- THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
- Mohsen Khosravi Maharlooei
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...
- Publication number 20240398954
- Publication date Dec 5, 2024
- IMMUNOMEDICS, INC.
- Serengulam V. Govindan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DRUG FORMULATION OF ANTI-HLA-DQ2.5 ANTIBODY
- Publication number 20240400693
- Publication date Dec 5, 2024
- Chugai SeiYaku Kabushiki Kaisha
- Kengo Arai
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CELIAC DISEASE EPITOPES
- Publication number 20240400692
- Publication date Dec 5, 2024
- NEXTERA AS
- Geir Åge LØSET
- G01 - MEASURING TESTING
Information Patent Application
DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...
- Publication number 20240398955
- Publication date Dec 5, 2024
- IMMUNOMEDICS, INC.
- Serengulam V. Govindan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOTHERAPY TARGETING TUMOR NEOANTIGENIC PEPTIDES
- Publication number 20240392010
- Publication date Nov 28, 2024
- INSTITUT CURIE
- Sebastian AMIGORENA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
T CELL RECEPTOR RECOGNIZING S37F MUTATION IN CTNNB1 AND ITS APPLICA...
- Publication number 20240390423
- Publication date Nov 28, 2024
- Yafei HOU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HLA-G AS A NOVEL TARGET FOR CAR T-CELL IMMUNOTHERAPY
- Publication number 20240392011
- Publication date Nov 28, 2024
- University of Southern California
- Alan L. Epstein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES
- Publication number 20240383986
- Publication date Nov 21, 2024
- Oxford University Innovation Limited
- Graham OGG
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES BINDING TO HLA-A2/MAGE-A4
- Publication number 20240383987
- Publication date Nov 21, 2024
- HOFFMANN-LA ROCHE INC.
- Tina Weinzierl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DUPLEXBODIES
- Publication number 20240376208
- Publication date Nov 14, 2024
- Affimed GmbH
- Uwe REUSCH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BAG6 SPECIFIC CHIMERIC ANTIGEN RECEPTOR, NUCLEIC ACID, BAG6 SPECIFI...
- Publication number 20240374726
- Publication date Nov 14, 2024
- China Medical University Hospital
- Der-Yang Cho
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MICA ANTIBODY WITH AFFINITY MATURATION AND USE THEREOF
- Publication number 20240368285
- Publication date Nov 7, 2024
- HEFEI TG IMMUNOPHARMA CO., LTD.
- Guoshuai CAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HLA-A2-SPECIFIC REGULATORY T CELLS
- Publication number 20240358833
- Publication date Oct 31, 2024
- The Regents of the University of California
- Qizhi TANG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PEPTIDE-CENTRIC CHIMERIC ANTIGEN RECEPTORS TO CANCER SELF-PEPTIDES
- Publication number 20240352130
- Publication date Oct 24, 2024
- The Children's Hospital of Philadelphia
- Matthew BEASLEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY-DRUG CONJUGATES AND USES THEREOF
- Publication number 20240350474
- Publication date Oct 24, 2024
- IMMUNOMEDICS, INC.
- David M. Goldenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROMOTING TRANSPLANTATION TOLERANCE
- Publication number 20240352129
- Publication date Oct 24, 2024
- The Brigham & Women's Hospital, Inc.
- Jamil Azzi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NOVEL PEPTIDES & COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGRE...
- Publication number 20240350602
- Publication date Oct 24, 2024
- Immatics Biotechnologies GmbH
- Andrea MAHR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TISSUE-DIRECTED ANTIBODIES AND METHODS OF USING THE SAME
- Publication number 20240342260
- Publication date Oct 17, 2024
- ZAG Bio, Inc.
- Alan Crane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS COMPRISING ANTIBODIES THAT BIND TO COVALEN...
- Publication number 20240327542
- Publication date Oct 3, 2024
- NEW YORK UNIVERSITY
- Shohei KOIDE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LABELING OF ANTIBODIES
- Publication number 20240325575
- Publication date Oct 3, 2024
- Whitehead Institute for Biomedical Research
- Mohammad Rashidian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VACCINE MOLECULES
- Publication number 20240325519
- Publication date Oct 3, 2024
- UNIVERSITY OF OSLO
- Gunnveig Grødeland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CELLS EXPRESSING CHIMERIC ACTIVATING RECEPTORS AND CHIMERIC STIMULA...
- Publication number 20240317855
- Publication date Sep 26, 2024
- Eureka Therapeutics, Inc.
- Hong LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RETARGETED RETROVIRAL VECTORS AND COMPOSITIONS OR METHODS OF USE TH...
- Publication number 20240294942
- Publication date Sep 5, 2024
- THE BROAD INSTITUTE, INC.
- Kepler MEARS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY...
- Publication number 20240294602
- Publication date Sep 5, 2024
- Immatics Biotechnologies GmbH
- Andrea MAHR
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-HLA-DQ2.5/8 ANTIBODY AND ITS USE FOR THE TREATMENT OF CELIAC D...
- Publication number 20240294649
- Publication date Sep 5, 2024
- Chugai SeiYaku Kabushiki Kaisha
- Yuu Okura
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MANAbodies AND METHODS OF USING
- Publication number 20240294648
- Publication date Sep 5, 2024
- The Johns Hopkins University
- Emily Han-Chung Hsiue
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING A HLA-A2/WT1 X CD3 BISPECIFIC ANTIBODY AN...
- Publication number 20240287193
- Publication date Aug 29, 2024
- HOFFMANN-LA ROCHE INC.
- Gerulf HAENEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

against MHC-molecules

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Peptides and combination of peptides for use in immunotherapy again...

MAGE-A4 peptide dual T cell engagers

BMA031 antigen binding polypeptides

CCR8 peptide and T cells for use in immunotherapeutic treatment of...

Anti-HLA-G antibodies and methods of use thereof

Peptides and combination of peptides and scaffolds thereof for use...

Immunotherapy targeting tumor neoantigenic peptides

Modified A1-A2 domains of non-natural NKG2D ligands that bind non-n...

T cell modification and use thereof

MIC antibodies and binding agents and methods of using the same

Anti-human papillomavirus (HPV) antigen-binding proteins and method...

Single domain antibodies targeting CD1d

Antibodies binding to HLA-A2/WT1

Peptides and combination of peptides for use in immunotherapy again...

Immunotherapy with B*07 restricted peptides and combination of pept...

A*03 restricted peptides for use in immunotherapy against cancers a...

Peptides and combination of peptides for use in immunotherapy again...

Anti-MICA/B antibodies that block MICA/B shedding and methods of use

Peptides and combination of peptides for use in immunotherapy again...

Peptides and combination of peptides and scaffolds for use in immun...

Peptides for use in immunotherapy against cancers

T cell receptors

Anti-ULBP6 antibodies

Peptides and combination of peptides for use in immunotherapy again...

Anti-hla-A2 antibodies and methods of using the same

Labeling of antibodies

Target peptides for immunotherapy and diagnostics

Peptides and combination of peptides as targets or active ingredien...

LILRB1-based chimeric antigen receptor

GINS2 peptide and T cells for use in immunotherapeutic treatment of...

Patents Applicationslast 30 patents

AUGMENTATION OF INNATE AND ADAPTIVE IMMUNITY BY INHIBITION OF INTER...

DUAL ACTING CD1D IMMUNOGLOBULIN FOR TREATMENT OF MYELODYSPLASTIC SY...

CONVERSION-RESISTANT / CONDITION-RESISTANT TREGS AND CAR TREGS, MET...

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...

DRUG FORMULATION OF ANTI-HLA-DQ2.5 ANTIBODY

CELIAC DISEASE EPITOPES

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...

IMMUNOTHERAPY TARGETING TUMOR NEOANTIGENIC PEPTIDES

T CELL RECEPTOR RECOGNIZING S37F MUTATION IN CTNNB1 AND ITS APPLICA...

HLA-G AS A NOVEL TARGET FOR CAR T-CELL IMMUNOTHERAPY

ANTIBODIES

ANTIBODIES BINDING TO HLA-A2/MAGE-A4

DUPLEXBODIES

BAG6 SPECIFIC CHIMERIC ANTIGEN RECEPTOR, NUCLEIC ACID, BAG6 SPECIFI...

MICA ANTIBODY WITH AFFINITY MATURATION AND USE THEREOF

HLA-A2-SPECIFIC REGULATORY T CELLS

PEPTIDE-CENTRIC CHIMERIC ANTIGEN RECEPTORS TO CANCER SELF-PEPTIDES

ANTIBODY-DRUG CONJUGATES AND USES THEREOF

PROMOTING TRANSPLANTATION TOLERANCE

NOVEL PEPTIDES & COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGRE...

TISSUE-DIRECTED ANTIBODIES AND METHODS OF USING THE SAME

COMPOSITIONS AND METHODS COMPRISING ANTIBODIES THAT BIND TO COVALEN...

LABELING OF ANTIBODIES

VACCINE MOLECULES

CELLS EXPRESSING CHIMERIC ACTIVATING RECEPTORS AND CHIMERIC STIMULA...

RETARGETED RETROVIRAL VECTORS AND COMPOSITIONS OR METHODS OF USE TH...

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY...

ANTI-HLA-DQ2.5/8 ANTIBODY AND ITS USE FOR THE TREATMENT OF CELIAC D...

MANAbodies AND METHODS OF USING

TREATMENT OF CANCER USING A HLA-A2/WT1 X CD3 BISPECIFIC ANTIBODY AN...